On the same morning, Geneseeq and AstraZeneca (“AstraZeneca”) (LSE/STO/Nasdaq: AZN) united with six other industry partners to establish Astrazeneca’s Lung Cancer Early Detection Alliance. Ms. Shanshan Yang, the Head of the Early Detection Program of Geneseeq, was invited to speak at the launching ceremony: “Geneseeq is willing to work with all members of the Lung Cancer Early Detection Alliance to combine resources and expertise to empower the development and application of lung cancer early screening and early diagnosis technologies.”

The post Geneseeq Forms Lung Cancer Strategic Partnerships with Takeda and AstraZeneca on the Same Day appeared first on Geneseeq Technology Inc. | A Precision Oncology Company.